Difficult packaging comes with tangible consequences, including lower adherence, higher rates of adverse events, and diminished real-world effectiveness. It can also delay FDA submissions and ultimately, market entry.
The post Our Aging Population is Forcing a Rethink of How We Design & Package Medicines appeared first on MedCity News.
